Research & Infrastructure

Burman et al., Clinical Infectious Diseases vol. 49 no. 3 August 1 2009 328-335.

IDSA published a statement outlining its concerns regarding excessive regulatory oversight and its impact on translational research and quality improvement projects. The statement provides recommendations to federal agencies and the research community on how to alleviate regulatory burdens thereby improving clinical research overall.

IDSA joined other organizations in support of new legislation to support public health capacity to identify and monitor the occurrence of infectious diseases and other conditions of public health importance, including laboratory capacity to detect antimicrobial resistant infections; and to improve electronic disease surveillance and reporting.

Hahm et al. The National Academies Press, Washington DC 2006.

Based on a 2003 workshop, this study describes current public and private programs and recommends ways to recruit and retain more women and underrepresented minorities into clinical research, especially physician-scientists and nurses.